Pages that link to "Q73182302"

The following pages link to Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer (Q73182302):

Displaying 29 items.

• Combination of physical activity, nutrition, or other metabolic factors and vaccine response (Q33751144) (← links)
• Prostate cancer postoperative nomogram scores and obesity (Q33841995) (← links)
• Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study (Q33986279) (← links)
• Human prostate cancer risk factors (Q34360616) (← links)
• Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study (Q34621809) (← links)
• Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. (Q34768848) (← links)
• The impact of obesity in urology (Q35763091) (← links)
• The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer (Q36090379) (← links)
• Examining the relationship between obesity and prostate cancer. (Q36598326) (← links)
• Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era (Q36952992) (← links)
• The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer (Q36992961) (← links)
• Clinicopathological and Prognostic Factors in 106 Prostate Cancer Patients Aged ≤55 Years: A Single-Center Study in China. (Q37368324) (← links)
• The evolving role of familial history for prostate cancer (Q37793100) (← links)
• Body mass index as a predictor of prostate cancer: development versus detection on biopsy (Q39722183) (← links)
• Leptin increases prostate cancer aggressiveness (Q39982630) (← links)
• Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer (Q40185822) (← links)
• Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy (Q40431540) (← links)
• Is central obesity, hyperinsulinemia and dyslipidemia associated with high-grade prostate cancer? A descriptive cross-sectional study (Q42590351) (← links)
• Robotic radical prostatectomy in overweight and obese patients: oncological and validated-functional outcomes (Q44250069) (← links)
• Impact of obesity on clinical outcomes in robotic prostatectomy (Q44904382) (← links)
• A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathological outcomes for obese men: an analysis of the Duke Prostate Center database (Q46834178) (← links)
• Impact of body mass index on outcomes after robot assisted radical prostatectomy (Q51903617) (← links)
• Effect of Body Mass Index on Histopathologic Parameters: Results of Large European Contemporary Consecutive Open Radical Prostatectomy Series (Q59649587) (← links)
• Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat (Q64075912) (← links)
• [Association of a positive family history with histopathology and clinical course in early-onset prostate cancer] (Q79145445) (← links)
• Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer (Q79794785) (← links)
• Time trends in pathologic features of radical prostatectomy--impact of family history (Q80374511) (← links)
• Obesity and prostate cancer (Q81550807) (← links)
• Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy (Q84877802) (← links)